Supplementary appendix

Size: px
Start display at page:

Download "Supplementary appendix"

Transcription

1 Supplementary appendix This appendix formed part of the original submission and has been peer reviewed. We post it as supplied by the authors. Supplement to: Leiter U, Stadler R, Mauch C, et al, for the German Dermatologic Cooperative Oncology Group (DeCOG). Complete lymph node dissection versus no dissection in patients with sentinel lymph node biopsy positive melanoma (DeCOG-SLT): a multicentre, randomised, phase 3 trial. Lancet Oncol 2016; published online May 5.

2 Supplementary material: Table 1: Patient characteristics of included vs. non-included patients. Included patients N = 473 Non-included patients N = 786 Gender male % % female % % Age at Diagnosis Median (IQR) 56 (45.0; 66.5) 62 (48.0; 70.0) <41 yrs % % yrs % % yrs % % yrs % % >70 yrs % % Body site trunk % % upper extremity % % lower extremity % % head and neck % others % Tumour thickness Median (IQR) 2.4 mm (1.6; 4.0) 2.4 mm (1.5; 4.0) 1.0 mm mm mm > 4.0 mm Ulceration present absent % % % % % % % % % % % % SN per patient > 3 n.a. Histological criteria H&E positive Immunhisto. pos. (S100, HMB45, Melan A) not specified Size of metastases SLNB single cells / <0,5 mm 0,5-1,00 mm 1,01-2,00 mm 2,01-5,00 mm 5, mm % % % % % % % % % % % 7 1.5% % % % 0 0% % % % % % % % % others % % Data are number of patients (%) unless otherwise indicated. Comparing both groups significant differences (p<0.05) were identified for age at diagnosis (p<0.001), number of SLN per patient (p<0.001), size of metastasis (p<0.001). 1

3 Table 2: Centers involved in the recruitment Centre Principal investigator Dept. of Dermatology, University of Tuebingen Dept. of Dermatology, Medical Hospital of Kassel Dept. of Dermatology, Medical Hospital of Erfurt Dept. of Dermatology, University of Cologne Dept. of Dermatology, University of Saarland Dept. of Dermatology, University of Berlin (Charité) Dept. of Dermatology, Gera and University of Jena Dept. of Surgery, University of Erlangen Dept. of Dermatology, University of Dresden Dept. of Dermatology, University of Magdeburg and Dept. of Dermatology, Medical Hospital of Quedlinburg Dept. of Dermatology, University of Duesseldorf Dept. of Dermatology, University of Leipzig Dept. of Dermatology, Medical Hospital of Minden Dept. of Dermatology, Medical Hospital of Cottbus Dept. of Dermatology, Medical Hospital of Karlsruhe Dept. of Dermatology, University of Regensburg Dept. of Dermatology, University of Muenster Dept. of Dermatology, University of Wuerzburg Dept. of Dermatology, Medical Hospital of Unna Dept. of Dermatology, University of Mainz Dept. of Dermatology, Ludwig-Maximilians University of Munich Dept. of Dermatology, University of Frankfurt/Main Dept. of Dermatology, Medical Hospital of Oldenburg Dept. of Dermatology, University of Luebeck Dept. of Dermatology, Medical Hospital of Berlin- Neukölln Dept. of Dermatology, University of Bochum Dept. of Dermatology, Medical Hospital of Dessau Dept. of Dermatology, University of Essen Dept. of Dermatology, Medical Hospital of Wuppertal Claus Garbe, MD Rainer Rompel, MD Rudolf Herbst, MD Cornelia Mauch, MD Thomas Vogt, MD Thorsten Zuberbier, MD Martin Kaatz, MD Werner Hohenberger, MD Stefan Beissert, MD Jens Ulrich, MD Klaus-Werner Schulte, MD Jan-Christoph Simon, MD Rudolf Stadler, MD Dieter Bachter, MD Wolfgang Gehring, MD Michael Landthaler, MD Cord Sunderkötter, MD Matthias Göbeler, MD Hans-Joachim Böhmer, MD Stephan Grabbe, MD Carola Berking, MD Roland Kaufmann, MD Erhard Hölzle, MD Detlef Zillikens, MD Peter Kohl, MD Norbert Brockmeyer, MD Christos Zouboulis, MD Dirk Schadendorf, MD Percy Lehmann, MD 2

4 Dept. of Dermatology, University of Heidelberg Dept. of Dermatology, Medical Hospital of Dresden- Friedrichstadt Dept. of Dermatology, University of Goettingen Dept. of Dermatology, Medical Hospital of Ludwigshafen Dept. of Dermatology, University of Mannheim Dept. of Dermatology, Medical Hospital of Detmold Dept. of Dermatology, Medical Hospital St. Georg, Hamburg Dept. of Dermatology, Medical Hospital of Darmstadt Dept. of Dermatology, University of Bonn Dept. of Dermatology, University of Marburg Dept. of Dermatology, Technical University of Munich Dept. of Dermatology, Medical Hospital of Zwickau Alexander Enk, MD Uwe Wollina, MD Michael Schön, MD Edgar Dippel, MD Jochen Utikal, MD Stefan Nestoris, MD Christian Sander, MD Maurizio Podda, MD Thomas Bieber, MD Michael Hertl, MD Johannes Ring, MD Dirk Mechtel, MD 3

5 Figure: Regional lymph node metastasis free survival in the further course of the disease: Arm A (observation, blue line) and arm B (CLND, red line) 4

Translating Evidence into Practice: Primary Cutaneous Melanoma Guidelines. Sentinel Lymph Node Biopsy

Translating Evidence into Practice: Primary Cutaneous Melanoma Guidelines. Sentinel Lymph Node Biopsy American Academy of Dermatology 2018 Annual Meeting San Diego, CA, February 17, 2018 Translating Evidence into Practice: Primary Cutaneous Melanoma Guidelines. Sentinel Lymph Node Biopsy Christopher Bichakjian,

More information

Supplementary appendix

Supplementary appendix Supplementary appendix This appendix formed part of the original submission and has been peer reviewed. We post it as supplied by the authors. Supplement to: Al-Batran S-E, Hofheinz RD, Pauligk C, et al.

More information

No Benefit to Routine Completion Lymphadenectomy for Sentinel Lymph Node Positive Melanoma

No Benefit to Routine Completion Lymphadenectomy for Sentinel Lymph Node Positive Melanoma No Benefit to Routine Completion Lymphadenectomy for Sentinel Lymph Node Positive Melanoma Michael Lowe, MD Assistant Professor of Surgery Winship Cancer Institute Emory University School of Medicine July

More information

Desmoplastic Melanoma: Surgical Management and Adjuvant Therapy

Desmoplastic Melanoma: Surgical Management and Adjuvant Therapy Desmoplastic Melanoma: Surgical Management and Adjuvant Therapy Dale Han, MD Assistant Professor Department of Surgery Section of Surgical Oncology No disclosures Background Desmoplastic melanoma (DM)

More information

Sentinel Node Alphabet Soup: MSLT-1, DeCOG-SLT, MSLT-2, UNC

Sentinel Node Alphabet Soup: MSLT-1, DeCOG-SLT, MSLT-2, UNC Sentinel Node Alphabet Soup: MSLT-1, DeCOG-SLT, MSLT-2, UNC David W. Ollila MD James and Jesse Millis Professor of Surgery University of North Carolina, Chapel Hill Disclosures: None July 15, 2018 AJCC

More information

Melanoma Patients and the Sentinel Lymph Node (SLN) Procedure: An Oncologic Surgeon s Perspective

Melanoma Patients and the Sentinel Lymph Node (SLN) Procedure: An Oncologic Surgeon s Perspective Melanoma Patients and the Sentinel Lymph Node (SLN) Procedure: An Oncologic Surgeon s Perspective Giorgos C. Karakousis, M.D. Associate Professor of Surgery Hospital of the University of Pennsylvania Disclosures

More information

Update on SLN and Melanoma: DECOG and MSLT-II. Gordon H. Hafner, MD, FACS

Update on SLN and Melanoma: DECOG and MSLT-II. Gordon H. Hafner, MD, FACS Update on SLN and Melanoma: DECOG and MSLT-II Gordon H. Hafner, MD, FACS No disclosures The surgery of malignant disease is not the surgery of organs, it is of the lymphatic system. Lord Moynihan Lymph

More information

Melanoma Quality Reporting

Melanoma Quality Reporting Melanoma Quality Reporting September 1, 2013 December 31, 2016 Laurence McCahill, MD Surgical Oncologist Metro Health Surgical Oncology Metro Health Professional Building 2122 Health Drive SW Wyoming,

More information

Melanoma Surgery Update James R. Ouellette, DO FACS Premier Health Cancer Institute Wright State University Chief, Surgical Oncology Division

Melanoma Surgery Update James R. Ouellette, DO FACS Premier Health Cancer Institute Wright State University Chief, Surgical Oncology Division Melanoma Surgery Update 2018 James R. Ouellette, DO FACS Premier Health Cancer Institute Wright State University Chief, Surgical Oncology Division Surgery for Melanoma Mainstay of treatment for potentially

More information

Surgical Oncology Perspective of Melanoma

Surgical Oncology Perspective of Melanoma Surgical Oncology Perspective of Melanoma Hans F. Schoellhammer, MD, FACS Assistant Clinical Professor Division of Surgical Oncology September 20, 2018 Nothing to disclose DISCLOSURE Discussion Objectives

More information

MELANOMA: THE BEST OF THE YEAR Dott.ssa Silvia Quadrini UOC Oncologia ASL Frosinone

MELANOMA: THE BEST OF THE YEAR Dott.ssa Silvia Quadrini UOC Oncologia ASL Frosinone MELANOMA: THE BEST OF THE YEAR 2018 Dott.ssa Silvia Quadrini UOC Oncologia ASL Frosinone The Best of the Year 2018: MELANOMA CHIRURGIA TERAPIA ADIUVANTE TERAPIA PER MALATTIA AVANZATA The Best of the Year

More information

Controversies and Questions in the Surgical Treatment of Melanoma

Controversies and Questions in the Surgical Treatment of Melanoma Controversies and Questions in the Surgical Treatment of Melanoma Giorgos C. Karakousis, M.D. Assistant Professor of Surgery Division of Endocrine and Oncologic Surgery University of Pennsylvania School

More information

Future of Research Research of the Future. Programme

Future of Research Research of the Future. Programme FAU s 275 th Anniversary Symposium Future of Research Research of the Future Programme Our anniversary partners: Cooperation Partner ZiWiS (Center for Applied Philosophy of Science and Key Qualifications)

More information

Adjuvant Chemotherapy With Gemcitabine and Cisplatin Compared to Observation After Curative Intent Resection of Biliary Tract Cancer (ACTICCA-1)

Adjuvant Chemotherapy With Gemcitabine and Cisplatin Compared to Observation After Curative Intent Resection of Biliary Tract Cancer (ACTICCA-1) A service of the U.S. National Institutes of Health Trial record 1 of 1 for: ACTICCA Previous Study Return to List Next Study Adjuvant Chemotherapy With Gemcitabine and Cisplatin Compared to Observation

More information

UvA-DARE (Digital Academic Repository) Who needs adjuvant therapy in stage III melanoma? Madu, M.F. Link to publication

UvA-DARE (Digital Academic Repository) Who needs adjuvant therapy in stage III melanoma? Madu, M.F. Link to publication UvA-DARE (Digital Academic Repository) Who needs adjuvant therapy in stage III melanoma? Madu, M.F. Link to publication Citation for published version (APA): Madu, M. F. (2018). Who needs adjuvant therapy

More information

Sentinel Lymph Node Biopsy: Past and Present Implications for the Management of Cutaneous Melanoma with Nodal Metastasis

Sentinel Lymph Node Biopsy: Past and Present Implications for the Management of Cutaneous Melanoma with Nodal Metastasis American Journal of Clinical Dermatology (2018) 19 (Suppl 1):S24 S30 https://doi.org/10.1007/s40257-018-0379-0 REVIEW ARTICLE Sentinel Lymph Node Biopsy: Past and Present Implications for the Management

More information

16 TH -17 TH INNOVATIONS IN ONCOLOGY NOVEMBER HEIDELBERG

16 TH -17 TH INNOVATIONS IN ONCOLOGY NOVEMBER HEIDELBERG 16 TH -17 TH 2015 NOVEMBER INNOVATIONS IN ONCOLOGY HEIDELBERG INNOVATIONS IN ONCOLOGY HEIDELBERG, NOVEMBER 16 TH - 17 TH 2015 German Cancer Research Center (DKFZ) Heidelberg - Germany Hosted by the National

More information

Cutaneous Melanoma: Epidemiology (USA) The Sentinel Node in Head and Neck Melanoma. Cutaneous Melanoma: Epidemiology (USA)

Cutaneous Melanoma: Epidemiology (USA) The Sentinel Node in Head and Neck Melanoma. Cutaneous Melanoma: Epidemiology (USA) The Sentinel Node in Head and Neck Melanoma Cutaneous Melanoma: Epidemiology (USA) 6 th leading cause of cancer among men and women 68,720 new cases of invasive melanoma in 2009 8,650 deaths from melanoma

More information

Sabrina Schmitt: "German Biobank Node s concept for quality management"

Sabrina Schmitt: German Biobank Node s concept for quality management Sabrina Schmitt: "German Biobank Node s concept for quality management" German Biobank Node s concept for quality management S. Schmitt K.-F. Becker, B. Meinung, E. Herpel, J. Slotta-Huspenina Sep-14-2016,

More information

Nodal Treatment in Melanoma: Snow to MSLT-II

Nodal Treatment in Melanoma: Snow to MSLT-II Nodal Treatment in Melanoma: Snow to MSLT-II Mark B. Faries, MD, FACS Director, Donald L. Morton Melanoma Research Program Program Director, JWCI Complex General Surgical Oncology Fellowship Director,

More information

Surgical Issues in Melanoma

Surgical Issues in Melanoma Surgical Issues in Melanoma Mark B. Faries, MD, FACS Director, Donald L. Morton Melanoma Research Program Director, Surgical Oncology Training Program Professor of Surgery John Wayne Cancer Institute Surgical

More information

Supplementary Appendix

Supplementary Appendix Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Rauen T, Eitner F, Fitzner C, et al. Intensive supportive care

More information

Prognosis of Sentinel Node Staged Patients with Primary Cutaneous Melanoma

Prognosis of Sentinel Node Staged Patients with Primary Cutaneous Melanoma Prognosis of Sentinel Node Staged Patients with Primary Cutaneous Melanoma Otmar Elsaeßer 1., Ulrike Leiter 1 *., Petra G. Buettner 2, Thomas K. Eigentler 1, Friedegund Meier 1, Benjamin Weide 1, Gisela

More information

Sentinel Lymph Node Biopsy for Breast Cancer

Sentinel Lymph Node Biopsy for Breast Cancer Sentinel Lymph Node Biopsy for Breast Cancer Registrar Tutorial Adam Cichowitz Surgical Registrar The Royal Melbourne Hospital Sentinel Lymph Node Biopsy Axillary LN status important prognostic factor

More information

17:00 17:45 Meet-the-Professor Immuno-Oncology Fan Yang, Beijing, Christoph Zielinski, Vienna

17:00 17:45 Meet-the-Professor Immuno-Oncology Fan Yang, Beijing, Christoph Zielinski, Vienna 8 th Chinese German Lung Cancer Forum Dresden, Germany, September 8-10, 2016 Precision oncology in lung cancer Thursday, September 8, 2016 17:00 17:45 Meet-the-Professor Immuno-Oncology Fan Yang, Beijing,

More information

Perioperative Chemotherapy Compared To Neoadjuvant Chemoradiation in Patients With Adenocarcinoma of the Esophagus (ESOPEC)

Perioperative Chemotherapy Compared To Neoadjuvant Chemoradiation in Patients With Adenocarcinoma of the Esophagus (ESOPEC) A service of the U.S. National Institutes of Health Trial record 1 of 1 for: esopec Previous Study Return to List Next Study Perioperative Chemotherapy Compared To Neoadjuvant Chemoradiation in Patients

More information

Hazard rates for recurrent and secondary cutaneous melanoma: An analysis of 33,384 patients in the German Central Malignant Melanoma Registry

Hazard rates for recurrent and secondary cutaneous melanoma: An analysis of 33,384 patients in the German Central Malignant Melanoma Registry Hazard rates for recurrent and secondary cutaneous melanoma: An analysis of 33,384 patients in the German Central Malignant Melanoma Registry Ulrike Leiter, MD, a Petra G. Buettner, PhD, b Thomas K. Eigentler,

More information

DFG. DFG Hinterzartener Kreis für Krebsforschung. From Molecular Mechanisms to Cancer Therapy. May 15-18, 2014 Villa La Collina Cadenabbia (Co), Italy

DFG. DFG Hinterzartener Kreis für Krebsforschung. From Molecular Mechanisms to Cancer Therapy. May 15-18, 2014 Villa La Collina Cadenabbia (Co), Italy DFG Hinterzartener Kreis für Krebsforschung From Molecular Mechanisms to Cancer Therapy May 15-18, 2014 Villa La Collina Cadenabbia (Co), Italy Program Committee Ursula Klingmüller, Heidelberg (Chair)

More information

Marshall T Bell Research Resident University of Colorado Grand Rounds Nov. 21, 2011

Marshall T Bell Research Resident University of Colorado Grand Rounds Nov. 21, 2011 Marshall T Bell Research Resident University of Colorado Grand Rounds Nov. 21, 2011 Most common form of cancer in adults ages 25-29 3-5% of skin cancers but 65-75% of deaths Most common metastasis to small

More information

Epithelial Cancer- NMSC & Melanoma

Epithelial Cancer- NMSC & Melanoma Epithelial Cancer- NMSC & Melanoma David Chin MB, BCh, BAO, LRCP, LRCS (Ireland) MCh(MD), PhD (UQ), FRCS, FRACS (Plast) Plastic & Reconstructive Surgeon Visiting Scientist Melanoma Genomic Group & Drug

More information

Who is the Ideal Candidate for PEG Intron?

Who is the Ideal Candidate for PEG Intron? Who is the Ideal Candidate for PEG Intron? Sanjiv S. Agarwala, MD Chief, Oncology & Hematology St. Luke s Cancer Center Professor, Temple University School of Medicine Philadelphia, PA, USA Overview Introduction

More information

Work-up/Follow-up: Baseline and Surveillance Studies for Cutaneous Melanoma Patients

Work-up/Follow-up: Baseline and Surveillance Studies for Cutaneous Melanoma Patients 2018 AAD Annual Meeting, San Diego, CA Work-up/Follow-up: Baseline and Surveillance Studies for Cutaneous Melanoma Patients Susan M. Swetter, MD, FAAD Professor of Dermatology Director, Pigmented Lesion

More information

Sentinel Lymph Node Biopsy in Other Tumours: Sentinel Lymph Node Biopsy in Other Tumours. Methodology. Results. Key Questions to Consider

Sentinel Lymph Node Biopsy in Other Tumours: Sentinel Lymph Node Biopsy in Other Tumours. Methodology. Results. Key Questions to Consider Sentinel Lymph Node Biopsy in Other Tumours Dr. Rona Cheifetz Surgical Oncology Update November 24, 2006 Sentinel Lymph Node Biopsy in Other Tumours: An Operation Looking for an Application Dr. Rona Cheifetz

More information

Medical Radiology. Diagnostic Imaging

Medical Radiology. Diagnostic Imaging Medical Radiology Diagnostic Imaging Series editors Hans-Ulrich Kauczor Hedvig Hricak Michael Knauth Editorial board Andy Adam, London Fred Avni, Brussels Richard L. Baron, Chicago Carlo Bartolozzi, Pisa

More information

Sentinel Lymph Node Biopsy: Current Evidence for its Role in Managing Melanoma

Sentinel Lymph Node Biopsy: Current Evidence for its Role in Managing Melanoma Sentinel Lymph Node Biopsy: Current Evidence for its Role in Managing Melanoma John A Zitelli MD Adjunct Clinical Associate Professor Dermatology, Otolaryngology, Plastic Surgery University of Pittsburgh

More information

PiCCA Study (Panitumumab in Combination With Cisplatin/Gemcitabine)

PiCCA Study (Panitumumab in Combination With Cisplatin/Gemcitabine) Page 1 of 6 Home Search Study Topics Glossary Search Study 1 of 1 for search of: NCT01320254 Previous Study Return to Search Results Next Study Full Text View Tabular View No Study Results Posted Related

More information

GBG/AGO-B study groups

GBG/AGO-B study groups Prediction of pathological complete response (pcr) by Homologous Recombination Deficiency (HRD) after carboplatin-containing neoadjuvant chemotherapy in patients with TNBC Results from GeparSixto. Gunter

More information

Update on Lymph Node Management in Melanoma

Update on Lymph Node Management in Melanoma Update on Lymph Node Management in Melanoma John T. Vetto MD, FACS Professor of Surgery Division of Surgical Oncology Oregon Health & Science University Portland, Oregon Lymph Nodes in Melanoma Outline

More information

Chemosaturation: Indication, Technique and Outcome

Chemosaturation: Indication, Technique and Outcome Chemosaturation: Indication, Technique and Outcome Thomas J Vogl, S Koch, B Gebauer, W Willinek, C Engelke, R Bruening, F Wacker, A Enk I D I R: Institute of Diagnostic and Interventional Radiology Goethe

More information

Rebecca Vogel, PGY-4 March 5, 2012

Rebecca Vogel, PGY-4 March 5, 2012 Rebecca Vogel, PGY-4 March 5, 2012 Historical Perspective Changes In The Staging System Studies That Started The Talk Where We Go From Here Cutaneous melanoma has become an increasingly growing problem,

More information

Radionuclide detection of sentinel lymph node

Radionuclide detection of sentinel lymph node Radionuclide detection of sentinel lymph node Sophia I. Koukouraki Assoc. Professor Department of Nuclear Medicine Medicine School, University of Crete 1 BACKGROUND The prognosis of malignant disease is

More information

Chapter 8. Timing Timing of Completion Lymphadenectomy after Positive Sentinel after Node Positive. Patients. Patients

Chapter 8. Timing Timing of Completion Lymphadenectomy after Positive Sentinel after Node Positive. Patients. Patients Timing of CLND 1 http://hdl.handle.net/1765/100861 Chapter 8 Timing Timing of Completion of Lymphadenectomy Lymphadenectomy after Positive Sentinel after Node Positive in Melanoma Sentinel Node in Melanoma

More information

Working Group on Health and Development

Working Group on Health and Development Katharina Anschütz KfW German Development Bank Katharina Böhm Ludwig- Maximilians- University, Munich katharina.anschuetz@kfw.de http://www.kfwentwicklungsbank.de/ebank/de_home/ Sektoren/Gesundheit/index.jsp

More information

Surgical Treatment of Melanoma Across the Disease Spectrum:

Surgical Treatment of Melanoma Across the Disease Spectrum: AOCD Annual Fall Meeting October 28 th, 2017 New Orleans, Louisiana Surgical Treatment of Melanoma Across the Disease Spectrum: Standards of Care and Evolving Paradigms Merrick Ross, M.D. Professor of

More information

Desmoplastic Melanoma R/O BCC. Clinical Information. 74 y.o. man with lesion on left side of neck r/o BCC

Desmoplastic Melanoma R/O BCC. Clinical Information. 74 y.o. man with lesion on left side of neck r/o BCC R/O BCC Sabine Kohler, M.D. Professor of Pathology and Dermatology Dermatopathology Service Stanford University School of Medicine Clinical Information 74 y.o. man with lesion on left side of neck r/o

More information

San Antonio Breast Cancer Symposium, December 5-9, San Antonio Breast Cancer Symposium, December 5-9, 2017

San Antonio Breast Cancer Symposium, December 5-9, San Antonio Breast Cancer Symposium, December 5-9, 2017 San Antonio Breast Cancer Symposium, December 5-9, 2017 Survival analysis of the prospectively randomized phase III GeparSepto trial comparing neoadjuvant chemotherapy with weekly nab-paclitaxel with solvent-based

More information

Molecular Enhancement of Sentinel Node Evaluation

Molecular Enhancement of Sentinel Node Evaluation Cochran Illustrations 060104 Molecular Enhancement of Sentinel Node Evaluation Alistair Cochran, MD and Rong Huang MD Departments of Pathology and Laboratory Medicine and Surgery, David Geffen School of

More information

Ravens Report. Götterdämmerung October 1, 4, 7, 11, 14, 17, 2017.

Ravens Report. Götterdämmerung October 1, 4, 7, 11, 14, 17, 2017. September 2017 Ravens Report Holländer September 8, 22, 2017. Lohengrin September 10, 16, 2017. Cologne Tannhäuser September 24, 30, 2017. Hagen Holländer September 10, 20, 2017. Hamburg Parsifal September

More information

Preventative/Preemptive Adoptive Transfer of Peptide Stimulated CMV/EBV Specific T-cells in Patients After Allogeneic Stem Cell Transplantation

Preventative/Preemptive Adoptive Transfer of Peptide Stimulated CMV/EBV Specific T-cells in Patients After Allogeneic Stem Cell Transplantation Find Studies About Studies Submit Studies Resources About Site Preventative/Preemptive Adoptive Transfer of Peptide Stimulated CMV/EBV Specific T-cells in Patients After Allogeneic Stem Cell Transplantation

More information

Nodal staging in localized melanoma. The experience of the Brescia Melanoma Unit

Nodal staging in localized melanoma. The experience of the Brescia Melanoma Unit The British Association of Plastic Surgeons (2003) 56, 534 539 Nodal staging in localized melanoma. The experience of the Brescia Melanoma Unit Giorgio Manca a, *, Fabio Facchetti b, Claudio Pizzocaro

More information

You Are Going to Cut How Much Skin? Locoregional Surgical Treatment. Justin Rivard MD, MSc, FRCSC September 21, 2018

You Are Going to Cut How Much Skin? Locoregional Surgical Treatment. Justin Rivard MD, MSc, FRCSC September 21, 2018 You Are Going to Cut How Much Skin? Locoregional Surgical Treatment Justin Rivard MD, MSc, FRCSC September 21, 2018 Presenter Disclosure Faculty/Speaker: Justin Rivard Relationships with financial sponsors:

More information

GBS 2018 Frankfurt Congress Program

GBS 2018 Frankfurt Congress Program GBS 2018 Frankfurt Congress Program Monday, September 17th 2018 08:30 17:00 On-site registration, Theodor-Stern-Kai 7, 60590 Frankfurt am Main GBS Young Investigators Session Chairs: Julia Hess (Munich)

More information

Follow-up investigations. Omgo E. Nieweg

Follow-up investigations. Omgo E. Nieweg Follow-up investigations Omgo E. Nieweg Systematic literature review follow-up investigations identify few patients with recurrence frequent false positive findings impact on survival unclear Nieweg, Surg

More information

Ultrasound Mapping of Lymph Node and Subcutaneous Metastases in Patients with Cutaneous Melanoma: Results of a Prospective Multicenter Study

Ultrasound Mapping of Lymph Node and Subcutaneous Metastases in Patients with Cutaneous Melanoma: Results of a Prospective Multicenter Study Clinical and Laboratory Investigations DOI: 10.1159/000089022 Received: November 29, 2004 Accepted: May 6, 2005 Ultrasound Mapping of Lymph Node and Subcutaneous Metastases in Patients with Cutaneous Melanoma:

More information

German Recommendations on Health Economic Evaluation: Third and Updated Version of the Hanover Consensus

German Recommendations on Health Economic Evaluation: Third and Updated Version of the Hanover Consensus Volume 11 Number 4 2008 VALUE IN HEALTH German Recommendations on Health Economic Evaluation: Third and Updated Version of the Hanover Consensus J.-Matthias Graf von der Schulenburg, PhD, 1 Wolfgang Greiner,

More information

Presentation outline

Presentation outline 4/7/217 Interpretation of survey data and opportunities in patient care Prof. Dr. med. T. Raupach, MME University Medical Centre Göttingen University College London Presentation outline 1) Patient-centred

More information

Disclosures. SLNB for Melanoma 25/02/2014 SENTINEL LYMPH NODE BIOPSY FOR MELANOMA: CURRENT GUIDELINES AND THEIR CLINICAL APPLICATION

Disclosures. SLNB for Melanoma 25/02/2014 SENTINEL LYMPH NODE BIOPSY FOR MELANOMA: CURRENT GUIDELINES AND THEIR CLINICAL APPLICATION 8 th Canadian Melanoma Conference February 22, 2014 Rimrock Resort Hotel, Banff, Alberta SENTINEL LYMPH NODE BIOPSY FOR MELANOMA: CURRENT GUIDELINES AND THEIR CLINICAL APPLICATION Christopher Bichakjian,

More information

Management of pediatric melanocytic lesions

Management of pediatric melanocytic lesions Open Journal of Clinical & Medical Case Reports Management of pediatric melanocytic lesions Volume 3 (2017) Issue 8 ISSN 2379-1039 Jin Kim, BS; Emmanuel Gabriel MD, PhD; Weiguo Liu MD, PhD; Lin Lin MD,

More information

Research Article Prediction of Sentinel Node Status and Clinical Outcome in a Melanoma Centre

Research Article Prediction of Sentinel Node Status and Clinical Outcome in a Melanoma Centre Skin Cancer Volume 2013, Article ID 904701, 7 pages http://dx.doi.org/10.1155/2013/904701 Research Article Prediction of Sentinel Node Status and Clinical Outcome in a Melanoma Centre Vera Teixeira, 1

More information

Measure #264: Sentinel Lymph Node Biopsy for Invasive Breast Cancer National Quality Strategy Domain: Effective Clinical Care

Measure #264: Sentinel Lymph Node Biopsy for Invasive Breast Cancer National Quality Strategy Domain: Effective Clinical Care Measure #264: Sentinel Lymph Node Biopsy for Invasive Breast Cancer National Quality Strategy Domain: Effective Clinical Care 2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY DESCRIPTION: The percentage

More information

Inguinal or inguino-iliac/obturator lymph node dissection after positive inguinal sentinel lymph node in patients with cutaneous melanoma

Inguinal or inguino-iliac/obturator lymph node dissection after positive inguinal sentinel lymph node in patients with cutaneous melanoma 258 research article Inguinal or inguino-iliac/obturator lymph node dissection after positive inguinal sentinel lymph node in patients with cutaneous melanoma Nebojsa Glumac 1, Marko Hocevar 1, Vesna Zadnik

More information

Evaluation of SIRFLOX Study Results. Prof. V. Heinemann CCC LMU, Klinikum Grosshadern Ludwig-Maximilian-University of Munich, Germany

Evaluation of SIRFLOX Study Results. Prof. V. Heinemann CCC LMU, Klinikum Grosshadern Ludwig-Maximilian-University of Munich, Germany Evaluation of SIRLX Study Results Prof. V. Heinemann CCC LMU, Klinikum Grosshadern Ludwig-Maximilian-University of Munich, Germany ESM Guideline: Response is a Goal of Treatment Performance Status of the

More information

Visceral. Medicine. Volume and Quality in Visceral. Medicine. Focus. Tobias Keck, Lübeck Klaus R. Herrlinger, Hamburg (Guest Editors)

Visceral. Medicine. Volume and Quality in Visceral. Medicine. Focus. Tobias Keck, Lübeck Klaus R. Herrlinger, Hamburg (Guest Editors) Vol. 33, Issue 2, April 2017 Visceral Gastroenterology, Endoscopy and Surgery The Interdisciplinary Approach to Gastrointestinal Disease Focus Tobias Keck, Lübeck Klaus R. Herrlinger, Hamburg (Guest Editors)

More information

When Do I Consider Myself Cured?

When Do I Consider Myself Cured? The Melanoma Patient Symposium - Science to Survivorship When Do I Consider Myself Cured? 26 September 2009 Jeffrey E. Gershenwald, MD, FACS Professor of Surgery, Dept. of Surgical Oncology Professor,

More information

Topics for Discussion. Malignant Melanoma. Surgical Treatment. Current Treatment of Cutaneous Melanoma 5/17/2013. Lymph Regional nodes:

Topics for Discussion. Malignant Melanoma. Surgical Treatment. Current Treatment of Cutaneous Melanoma 5/17/2013. Lymph Regional nodes: Topics for Discussion What is a sentinel lymph node (SLN)? Utility of sentinel lymph biopsies: therapeutic or staging? Current Treatment of Cutaneous Melanoma Carlos Corvera, M.D. Associate Professor of

More information

Michael T. Tetzlaff MD, PhD

Michael T. Tetzlaff MD, PhD American Joint Cancer Committee (AJCC) staging system for primary cutaneous melanoma (8 th Edition) and principles of sentinel lymph node evaluation Emphasis on concise and accurate reporting of primary

More information

6/22/2015. Original Paradigm. Correlating Histology and Molecular Findings in Melanocytic Neoplasms

6/22/2015. Original Paradigm. Correlating Histology and Molecular Findings in Melanocytic Neoplasms 6 Correlating Histology and Molecular Findings in Melanocytic Neoplasms Pedram Gerami MD, Associate Professor of Dermatology and Pediatrics at Northwestern University Disclosures: I have been a consultant

More information

Protocol applies to melanoma of cutaneous surfaces only.

Protocol applies to melanoma of cutaneous surfaces only. Melanoma of the Skin Protocol applies to melanoma of cutaneous surfaces only. Procedures Biopsy (No Accompanying Checklist) Excision Re-excision Protocol revision date: January 2005 Based on AJCC/UICC

More information

Updates on management of the axilla in breast cancer the surgical point of view

Updates on management of the axilla in breast cancer the surgical point of view Updates on management of the axilla in breast cancer the surgical point of view Edwige Bourstyn Centre des maladies du sein Hôpital Saint Louis Paris Sentinel lymph node biopsy (SLNB) is the standard of

More information

International Symposium

International Symposium January 21 to 23, 2010 Berlin, Germany New Molecular Pathomechanisms and Novel Therapeutic Approaches in Heart Failure Scientific Committee Heinz-Peter Schultheiss Carsten Tschoepe Wolfgang Poller Dept.

More information

Optimal extent of completion lymphadenectomy for patients with melanoma and a positive sentinel node in the groin

Optimal extent of completion lymphadenectomy for patients with melanoma and a positive sentinel node in the groin Original article Optimal extent of completion lymphadenectomy for patients with melanoma and a positive sentinel node in the groin D. Verver 1,M.F.Madu 2, C. M. C. Oude Ophuis 1,M.Faut 3,J.H.W.deWilt 4,

More information

Impact of Prognostic Factors

Impact of Prognostic Factors Melanoma Prognostic Factors: where we started, where are we going? Impact of Prognostic Factors Staging Management Surgical intervention Adjuvant treatment Suraj Venna, MD Assistant Clinical Professor,

More information

Chapter 2. Melanoma. A Dutch Population Based Study

Chapter 2. Melanoma. A Dutch Population Based Study Implementation AJCC staging thin melanomas 1 http://hdl.handle.net/1765/100861 Chapter 2 Implementation of of the 7th Edition Edition AJCC AJCC Staging System: Effects Effects on Staging on and Staging

More information

Advances in Surgical Management of Primary Melanoma: Identifying Patients Who Need More than Conventional Wide Local Excision

Advances in Surgical Management of Primary Melanoma: Identifying Patients Who Need More than Conventional Wide Local Excision Advances in Surgical Management of Primary Melanoma: Identifying Patients Who Need More than Conventional Wide Local Excision Christopher J. Miller, MD Director of Penn Dermatology Oncology Center Associate

More information

Quantification of Melanoma Micrometastases in Sentinel Lymph Nodes Using Real-Time RT-PCR

Quantification of Melanoma Micrometastases in Sentinel Lymph Nodes Using Real-Time RT-PCR See related Commentaries on pages vi and xiv Quantification of Melanoma Micrometastases in Sentinel Lymph Nodes Using Real-Time RT-PCR Thomas Giese, Monika Engstner,w Ulrich Mansmann,z Wolfgang Hartschuh,w

More information

Diagnostics of Pancreatic Carcinoma

Diagnostics of Pancreatic Carcinoma Diagnostics of Pancreatic Carcinoma Jens Ricke Charité - Universitätsmedizin Berlin Klinik für Strahlenheilkunde (Director: Prof. Dr. Dr. Roland Felix) Imaging in Pancreatic Carcinoma CT MRT ERCP? FDG-PET

More information

ORIGINAL ARTICLE. Clinical Node-Negative Thick Melanoma

ORIGINAL ARTICLE. Clinical Node-Negative Thick Melanoma ORIGINAL ARTICLE Clinical Node-Negative Thick Melanoma George I. Salti, MD; Ashwin Kansagra, MD; Michael A. Warso, MD; Salve G. Ronan, MD ; Tapas K. Das Gupta, MD, PhD, DSc Background: Patients with T4

More information

Quality ID #264: Sentinel Lymph Node Biopsy for Invasive Breast Cancer National Quality Strategy Domain: Effective Clinical Care

Quality ID #264: Sentinel Lymph Node Biopsy for Invasive Breast Cancer National Quality Strategy Domain: Effective Clinical Care Quality ID #264: Sentinel Lymph de Biopsy for Invasive Breast Cancer National Quality Strategy Domain: Effective Clinical Care 2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY MEASURE TYPE: Process

More information

PHASE I STUDY WITH PHOTOCHEMICAL INTERNALISATION (PCI)- A NOVEL TECHNOLOGY FOR TREATMENT OF PERIHILAR CHOLANGIOCARCINOMA

PHASE I STUDY WITH PHOTOCHEMICAL INTERNALISATION (PCI)- A NOVEL TECHNOLOGY FOR TREATMENT OF PERIHILAR CHOLANGIOCARCINOMA PHASE I STUDY WITH PHOTOCHEMICAL INTERNALISATION (PCI)- A NOVEL TECHNOLOGY FOR TREATMENT OF PERIHILAR CHOLANGIOCARCINOMA Richard Sturgess 1, Dan Palmer 1, Jörg Trojan 2, Albrecht Hoffmeister 3, Bruno Neu

More information

ALND. Dr. MJ Vrancken

ALND. Dr. MJ Vrancken ALND Dr. MJ Vrancken ALND in primary surgery se1ng Axillary lymph node dissec8on (ALND) Very nice opera8on; dorsal approach 2 ALND in primary surgery se1ng Axillary lymph node dissec8on (ALND) Very nice

More information

Funding of patient-oriented clinical research by the German Federal Ministry of Education and Research (BMBF)

Funding of patient-oriented clinical research by the German Federal Ministry of Education and Research (BMBF) Funding of patient-oriented clinical research by the German Federal Ministry of Education and Research (BMBF) Dr. Steinmüller/ Dr. Jacobs July 8th, 2011, Cologne Overview Health research programme of the

More information

UvA-DARE (Digital Academic Repository) Who needs adjuvant therapy in stage III melanoma? Madu, M.F. Link to publication

UvA-DARE (Digital Academic Repository) Who needs adjuvant therapy in stage III melanoma? Madu, M.F. Link to publication UvA-DARE (Digital Academic Repository) Who needs adjuvant therapy in stage III melanoma? Madu, M.F. Link to publication Citation for published version (APA): Madu, M. F. (2018). Who needs adjuvant therapy

More information

How can we reduce the mortality from melanoma in Australia?

How can we reduce the mortality from melanoma in Australia? How can we reduce the mortality from melanoma in Australia? Professor Grant McArthur MB BS PhD Peter MacCallum Cancer Centre Melbourne, Australia University of Melbourne, Parkville, Australia What is melanoma?

More information

Appropriate Concept of Prevention of Lymphedema at the Initial Treatment

Appropriate Concept of Prevention of Lymphedema at the Initial Treatment Global Breast Cancer Conference 2018 Appropriate Concept of Prevention of Lymphedema at the Initial Treatment Zisun Kim Department of Surgery, Soonchunhyang University Bucheon Hospital, Soonchunhyang University

More information

Surgical Considerations in Breast Cancer treated with Neoadjuvant Therapy

Surgical Considerations in Breast Cancer treated with Neoadjuvant Therapy Surgical Considerations in Breast Cancer treated with Neoadjuvant Therapy Rebecca Warburton MD Department of Surgery, University of British Columbia Mount Saint Joseph Hospital, Providence Health Care

More information

Advanced ICAS Training Course on "Wound Healing and its Disturbances" February 2005

Advanced ICAS Training Course on Wound Healing and its Disturbances February 2005 Advanced ICAS Training Course on "Wound Healing and its Disturbances" 14-18 February 2005 at the Institute for Laser Technologies in Medicine (ILM) at the Helmholtzstrasse 12, 89081 Ulm, Germany Course

More information

Clinical utilities and biological characteristics of melanoma sentinel lymph nodes

Clinical utilities and biological characteristics of melanoma sentinel lymph nodes W J C O World Journal of Clinical Oncology Submit a Manuscript: http://www.wjgnet.com/esps/ Help Desk: http://www.wjgnet.com/esps/helpdesk.aspx DOI: 10.5306/wjco.v7.i2.174 World J Clin Oncol 2016 April

More information

Treatment and management of advanced melanoma: Paul B. Chapman, MD Melanoma Clinical Director, Melanoma and Immunotherapeutics Service MSKCC

Treatment and management of advanced melanoma: Paul B. Chapman, MD Melanoma Clinical Director, Melanoma and Immunotherapeutics Service MSKCC Treatment and management of advanced melanoma: 2018 Paul B. Chapman, MD Melanoma Clinical Director, Melanoma and Immunotherapeutics Service MSKCC Disclosure Paul B. Chapman, MD Nothing to disclose. Off

More information

> 6000 Mutations in Melanoma. Tests That Cay Be Employed. FISH for Additions/Deletions. Comparative Genomic Hybridization

> 6000 Mutations in Melanoma. Tests That Cay Be Employed. FISH for Additions/Deletions. Comparative Genomic Hybridization Winter Clinical 2017: The Assessment and Diagnosis of Melanoma Whitney A. High, MD, JD, MEng Associate Professor, Dermatology & Pathology Director of Dermatopathology (Dermatology) University of Colorado

More information

Genetic Testing: When should it be ordered? Julie Schloemer, MD Dermatology

Genetic Testing: When should it be ordered? Julie Schloemer, MD Dermatology Genetic Testing: When should it be ordered? Julie Schloemer, MD Dermatology Outline Germline testing CDKN2A BRCA2 BAP1 Somatic testing Gene expression profiling (GEP) BRAF Germline vs Somatic testing

More information

Braun-Falco s Dermatology

Braun-Falco s Dermatology Braun-Falco s Dermatology Bearbeitet von Walter Burgdorf, Gerd Plewig, Helmut Heinrich Wolff, Michael Landthaler Neuausgabe 2008. Buch. xxxviii, 1711 S. Hardcover ISBN 978 3 540 29312 5 Format (B x L):

More information

Presented at the European Society of Medical Oncology (ESMO), Munich, Germany, October 2018

Presented at the European Society of Medical Oncology (ESMO), Munich, Germany, October 2018 Effectiveness of afatinib in clinical practice first results of the GIDEON trial: a prospective non-interventional study in EGFR-mutated NSCLC in Germany Wolfgang M. Brueckl 1 *, Eckart Laack 2, Martin

More information

CONSENSUS ULTRASOUND SURVEILLANCE PROTOCOL AFTER POSITIVE SENTINEL LYMPH NODE BIOPSY FOR MELANOMA

CONSENSUS ULTRASOUND SURVEILLANCE PROTOCOL AFTER POSITIVE SENTINEL LYMPH NODE BIOPSY FOR MELANOMA CONSENSUS ULTRASOUND SURVEILLANCE PROTOCOL AFTER POSITIVE SENTINEL LYMPH NODE BIOPSY FOR MELANOMA Created by Drs P. Robins, Z. Al-Ogaili and B. Adler in collaboration with the WA Kirkbride Melanoma Advisory

More information

Skin Malignancies Non - Melanoma & Melanoma Marilyn Ng, MD Dept. of Surgery M&M Conference Downstate Medical Center July 19, 2012

Skin Malignancies Non - Melanoma & Melanoma Marilyn Ng, MD Dept. of Surgery M&M Conference Downstate Medical Center July 19, 2012 Skin Malignancies Non - Melanoma & Melanoma Marilyn Ng, MD Dept. of Surgery M&M Conference Downstate Medical Center July 19, 2012 Case Presentation 57 yo man with 3 month hx of a nonhealing < 1 cm right

More information

Programme. Deutsche Messe Hannover Convention Center. Wednesday h Opening of the trade exhibition of the hearing instruments industry

Programme. Deutsche Messe Hannover Convention Center. Wednesday h Opening of the trade exhibition of the hearing instruments industry Wednesday 17.10.2018 9 00 h Opening of the trade exhibition of the hearing instruments industry 12 00 h Opening reception 12 30 14 00 h Opening ceremony and keynote address: Peter Holzer, Frechen Remaining

More information

Zurich Open Repository and Archive. Long-term survival of glioblastoma patients treated with radiotherapy and lomustine plus temozolomide

Zurich Open Repository and Archive. Long-term survival of glioblastoma patients treated with radiotherapy and lomustine plus temozolomide University of Zurich Zurich Open Repository and Archive Winterthurerstr. 19 CH-857 Zurich http://www.zora.uzh.ch Year: 29 Long-term survival of glioblastoma patients treated with radiotherapy and lomustine

More information

Clinical Case Conference Melanoma

Clinical Case Conference Melanoma Clinical Case Conference Melanoma Epidemiology ~60,000 cases and 8,000 deaths per year in US Caucasian:African American = 10:1 15% arise from existing nevi 91% are cutaneous 15% are LN+ at presentation

More information

MELANOMA LETTER. Surgical Treatment of Primary Melanoma: Where Do We Stand After MSLT-II? THE. From the Editors MSLT-II. SkinCancer.

MELANOMA LETTER. Surgical Treatment of Primary Melanoma: Where Do We Stand After MSLT-II? THE. From the Editors MSLT-II. SkinCancer. THE MELANOMA LETTER A PUBLICATION OF THE SKIN CANCER FOUNDATION DEBORAH S. SARNOFF, MD, President WINTER 2017, Vol. 35 DAN LATORE, Executive Director Surgical Treatment of Primary Melanoma: Where Do We

More information

Springer Healthcare. Staging and Diagnosing Cutaneous Melanoma. Concise Reference. Dirk Schadendorf, Corinna Kochs, Elisabeth Livingstone

Springer Healthcare. Staging and Diagnosing Cutaneous Melanoma. Concise Reference. Dirk Schadendorf, Corinna Kochs, Elisabeth Livingstone Concise Reference Staging and Diagnosing Cutaneous Melanoma Dirk Schadendorf, Corinna Kochs, Elisabeth Livingstone Extracted from Handbook of Cutaneous Melanoma: A Guide to Diagnosis and Treatment Published

More information

01 The DGVM - the Association for Associations

01 The DGVM - the Association for Associations 01 The DGVM - the Association for Associations In Germany there are around 14,300 associations and comparable organisations with a professional management. These associations differ greatly in their field

More information